Retinoic Acid Signaling in Neural Patterning
Introduction to Retinoic Acid
Retinoic acid, a key metabolite of vitamin A1, has shown its significant role in regulating the differentiation and proliferation of vitamin A1. Previous studies have demonstrated that all-trans-retinoic acid is essential for the growth of all chordates, ranging from fish to humans. The synthesis of retinoic acid consists of alcohol dehydrogenase and retinal dehydrogenase. The level of retinoic acid signaling is also mediated by retinoic acid-binding protein and retinol-binding proteins. Recently, all-trans-retinoic acid has been regarded as an intercellular signaling molecule to mediate the development of the anterior/posterior of the embryo. Moreover, retinoic acid can bind with retinoic acid receptors and retinoid X receptors to control the activation or release of various co-activators and co-inhibitors.
Fig.1 Pathways involved in how retinoic acid is produced, acted upon, and catabolized.1
Retinoic Acid Signaling Pathway
Retinyl ester is hydrolyzed by microsomal carboxylesterase and other lipases to produce retinol, which is released into the bloodstream to form the retinol-binding complex protein 4(RBP4). Retinol/RBP4 complex can interact with STRA6 to bind its target cells. Furthermore, retinol binds to retinol-binding protein 1 and is oxidized to retinal by different kinds of retinol dehydrogenases, like RDH10 and Rdh1. Retinal will be catalyzed by a variety of retinal dehydrogenases, such as RALDH1, Aldh8a1, and Aldh1a1, to eventually converted to all-trans retinoic acid. All-trans retinoic acid is bind to its binding proteins to enter the nucleus. In the nucleus, retinoic acid can bind with the nuclear retinoic acid receptors and retinoid X receptors, including RARα, RARβ, RARγ, as well as RXRα to participate in a wide spectrum of tissue development processes.
Retinoic Acid Signaling in Neural Patterning
Currently, the role of retinoic acid signaling in neural patterning is becoming increasingly apparent. Recent studies have revealed that retinoic acid is associated with the differentiation, growth, development, regeneration of the nervous system. Numerous data have indicated that retinoic acid can be treated as a novel therapeutic molecule for mediating axon regeneration and treating various neurodegenerative diseases. During neural development, retinoic acid is used in conjunction with the supersonic hedgehog gene and bone morphogenetic protein to form the dorsal-ventral axis of the neural tube. Besides, retinoic acid can also regulate the differentiation of different neurons and glial cells by activating several signaling molecules, proteins, enzymes, and gene encoding transcription factors. Retinoic acid can act indirectly on neurons to stimulate the regenerative response. In the mature central nervous system, retinoic acid plays a significant role in maintaining plasticity and the production of neural stem cells. As a result. retinoic acid has been considered as a potential treatment target for neurological diseases, such as Parkinson's disease and Parkinson's disease.
Creative Biolabs concentrates on promoting the understanding of retinoic acid signaling in neural patterning. We will combine the many advanced analysis tools with other incredible technologies around the world to boost novel drug discovery in unprecedented ways. In our company, our scientists specialized in neurological disease studies will work with you to develop the most appropriate strategy that will offer reproducible data for your research. If you are interested in our services, please feel free to contact us for closer communication to learn how we can be involved in your project. Separate services or integrated end-to-end solutions are all welcomed.
Reference
- Diez del Corral, Ruth, and Aixa V. Morales. "Retinoic acid signaling during early spinal cord development." Journal of Developmental Biology 2.3 (2014): 174-197. Distributed under Open Access license CC BY 3.0, without modification.
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)